Published in Virology on January 05, 2001
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin (2008) 1.99
Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog (2009) 1.82
Review: The neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol (2011) 1.45
Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc (2012) 1.18
Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation. J Neurovirol (2010) 1.16
Simian varicella virus pathogenesis. Curr Top Microbiol Immunol (2010) 1.08
Simian varicella virus expresses a latency-associated transcript that is antisense to open reading frame 61 (ICP0) mRNA in neural ganglia of latently infected monkeys. J Virol (2007) 1.04
Simian varicella in old world monkeys. Comp Med (2008) 1.02
The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep (2013) 0.98
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J Gen Virol (2015) 0.93
T-Cell tropism of simian varicella virus during primary infection. PLoS Pathog (2013) 0.92
Varicella zoster virus infection. Nat Rev Dis Prim (2015) 0.90
Simian varicella virus infection of Chinese rhesus macaques produces ganglionic infection in the absence of rash. J Neurovirol (2012) 0.85
Clinical and molecular aspects of varicella zoster virus infection. Future Neurol (2009) 0.84
Herpes zoster and the search for an effective vaccine. Clin Exp Immunol (2016) 0.81
Robust pro-inflammatory and lesser anti-inflammatory immune responses during primary simian varicella virus infection and reactivation in rhesus macaques. J Neurovirol (2014) 0.80
Varicella Zoster Virus in the Nervous System. F1000Res (2015) 0.79
Animal models of varicella zoster virus infection. Pathogens (2013) 0.78
Simian Varicella Virus Is Present in Macrophages, Dendritic Cells, and T Cells in Lymph Nodes of Rhesus Macaques after Experimental Reactivation. J Virol (2015) 0.77
Characterization of the immune response in ganglia after primary simian varicella virus infection. J Neurovirol (2015) 0.76
Pathogenesis of varicelloviruses in primates. J Pathol (2015) 0.76
Zeroing in on zoster: A tale of many disorders produced by one virus. J Neurol Sci (2015) 0.75
Acute Simian Varicella Virus Infection Causes Robust and Sustained Changes in Gene Expression in the Sensory Ganglia. J Virol (2016) 0.75
Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med (2000) 6.43
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
Molecular genetic basis of the histo-blood group ABO system. Nature (1990) 4.17
Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology (1996) 4.02
List-mode likelihood. J Opt Soc Am A Opt Image Sci Vis (1997) 3.86
Common data model for neuroscience data and data model exchange. J Am Med Inform Assoc (2001) 3.10
Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry (2001) 3.00
Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int (1995) 2.97
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology (2007) 2.76
Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med (1990) 2.75
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71
Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology (2011) 2.71
Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
Concussion in sports. Guidelines for the prevention of catastrophic outcome. JAMA (1991) 2.53
Electron transport chain defects in Alzheimer's disease brain. Neurology (1994) 2.51
Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A (1981) 2.45
Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol (1996) 2.41
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Environment and behavior of 2.5-million-year-old Bouri hominids. Science (1999) 2.36
Varicella-zoster virus DNA in human sensory ganglia. Nature (1984) 2.34
Primary intraosseous meningioma. Case report. J Neurosurg (1995) 2.28
Toxic leukoencephalopathy. N Engl J Med (2001) 2.27
Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med (2001) 2.18
A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid. Studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism. Clin Exp Immunol (1968) 2.17
Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology (1998) 2.17
Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes. DNA (1984) 2.04
Australopithecus garhi: a new species of early hominid from Ethiopia. Science (1999) 1.91
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol (2008) 1.88
Adipsin and complement factor D activity: an immune-related defect in obesity. Science (1989) 1.87
Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology (2000) 1.84
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.79
Search for varicella zoster virus in giant cell arteritis. Ann Neurol (1998) 1.78
A randomised controlled study of close monitoring of vulnerable psychiatric patients. Lancet (1995) 1.76
Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med (2003) 1.75
Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes (2001) 1.75
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66
Neanderthal cannibalism at Moula-Guercy, Ardèche, France. Science (1999) 1.66
Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J Virol (1995) 1.66
The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol (2001) 1.65
Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol (1992) 1.65
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol (2000) 1.64
Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology (1984) 1.64
Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry (1999) 1.60
Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol (1998) 1.59
Extraction of cell-associated varicella-zoster virus DNA with triton X-100-NaCl. J Virol Methods (1982) 1.58
Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia. J Infect Dis (1992) 1.52
Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science (1981) 1.52
Proximal nerve root spinal hemangioblastomas: presentation of three cases, MR appearance, and literature review. Surg Neurol (2004) 1.49
A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol (1994) 1.47
School absenteeism, parental work loss, and acceptance of childhood influenza vaccination. Am J Med Sci (2001) 1.46
Varicella-zoster virus infection of human mononuclear cells. Virus Res (1987) 1.46
CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology (2005) 1.45
Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. J Virol (1993) 1.41
VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41
Geology and palaeontology of the Late Miocene Middle Awash valley, Afar rift, Ethiopia. Nature (2001) 1.41
Low serum iron levels and neuroleptic malignant syndrome. Am J Psychiatry (1991) 1.40
The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia. Am J Psychiatry (1992) 1.39
Low serum iron status and akathisia. Lancet (1987) 1.38
Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol (1984) 1.38
Human leucocyte antigens and tardive dyskinesia. Br J Psychiatry (1991) 1.38
The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol (1995) 1.36
Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry (2000) 1.33
Diffuse Lewy body disease and progressive dementia. Neurology (1988) 1.31
Isolation of Herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet (1977) 1.30
Lymphomatosis cerebri as a cause of white matter dementia. Hum Pathol (2005) 1.30
Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain. J Neuroimmunol (1999) 1.28
An adult case of leukoencephalopathy with intracranial calcifications and cysts. Neurology (2006) 1.28
Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J Virol (1999) 1.25
Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol (1996) 1.25
The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol (1991) 1.25
Validation of nonradioactive chemiluminescent immunoassay methods for the analysis of thyroxine and cortisol in blood samples obtained from dogs, cats, and horses. J Vet Diagn Invest (1997) 1.24
Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol (1988) 1.24
Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells. DNA Cell Biol (1997) 1.23
Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli. Proc Natl Acad Sci U S A (1981) 1.23
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res (2011) 1.22
Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task. Psychol Med (2001) 1.22
Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci (1996) 1.22
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol (1973) 1.21
An algorithmic approach to the brain biopsy--part II. Arch Pathol Lab Med (2006) 1.21
Preherpetic neuralgia. Neurology (1991) 1.20
Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A (2001) 1.19
Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci (2000) 1.19
Zoster myelitis: improvement with antiviral therapy in two cases. Neurology (1996) 1.19
Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol (1995) 1.18
N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci (2001) 1.18